ESC Congress 2026 Abstract
Impact of different exercise training modalities on patient-reported outcomes in heart failure with reduced and preserved ejection fraction
Randomized trial in 367 peopleModerate-intensity continuous training
Kansas City Cardiomyopathy Questionnaire Overall Summary score
Papers on Kansas City Cardiomyopathy Questionnaire Overall Summary score
9 papers3 new in 30 days
Monday, October 26
ESC Congress 2026 Abstract
Exploring the impact of age and comorbidities on quality-of-life improvements with empagliflozin: findings from a broad European real-world population
Cohort study of 3,108 peopleEmpagliflozin
ESC Congress 2026 Abstract
Sex-specific differences in patient-centered outcomes after transcatheter aortic valve replacement
Study of 732 peopleInterventions
Wednesday, May 6
Wednesday, March 18
Journal of the American Heart Association
Clinical, Functional, and Quality-of-Life Outcomes After Contemporary Transcatheter Edge-to-Edge Repair for Primary Mitral Regurgitation in the Very Elderly
Cohort study of 854 peopleMitral regurgitation
Wednesday, October 29
European Journal of Heart Failure
Efficacy and safety of vutrisiran in transthyretin amyloid cardiomyopathy across the age spectrum: The HELIOS-B trial
Randomized trial in 654 peopleTransthyretin amyloid cardiomyopathy
Sunday, July 20
JACC Advances
Noninvasive Screening for Elevated LVEDP and Health Status in Outpatients at Risk for Heart Failure
Cross-sectional study of 2,040 peopleHeart failure
Thursday, November 9
JACC Heart Failure
Tafamidis Efficacy Among Octogenarian Patients in the Phase 3 ATTR-ACT and Ongoing Long-Term Extension Study
Randomized trial in peopleInterventions
Sunday, August 28
Circulation
Efficacy and Safety of Dapagliflozin According to Frailty in Patients With Heart Failure: A Prespecified Analysis of the DELIVER Trial
Randomized trial in 6,263 peopleDapagliflozin